Tuberous sclerosis complex (TSC) is an autosomal dominant inherited disorder characterized by benign tumors (hamartomas) in various organs. The brain is one of the most severely affected organs with neuropsychiatric disorders including epilepsy, mental retardation and autism. The identification of TSC genes (TSC1 and TSC2) and their gene products (hamartin and tuberin, respectively), revealed that they function together as a complex. However, mutations in TSC2 are often accompanied by more severe neurologic deficits. Here, we show that hamartin and tuberin play different roles in NGF-treated cultured neuronal cells PC12h. The level of hamartin in PC12h cells was slightly and gradually increased, while those of tuberin rapidly increased upon NGF-induced neuronal differentiation in PC12h cells. Antisense for TSC1 (TSC1-AS) or TSC2-AS reduced expression of hamartin or tuberin, respectively, and enhanced S-phase of cell cycle in PC12h cells. Suppression of hamartin significantly enhanced neurite outgrowth after NGFtreatment in PC12h cells, while suppression of tuberin inhibited neurite outgrowth. Expression of activated V14RhoA reverted TSC1-AS induced abnormal neurite development. These results suggest that loss of hamartin results in abnormal neurite elongation through Rho inactivation in NGF-treated PC12h cells, which may be associated with the neurological manifestations of TSC.
Introduction
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder affecting 1 in 6000-10,000 births [1, 2] . Two causative genes were identified as tumor suppressor genes, TSC1 (chromosome 9q34) and TSC2 (chromosome 16p13.3), which encode hamartin and tuberin, respectively [3, 4] . Both familial and sporadic TSC cases occur. Among sporadic TSC cases, mutations in TSC2 are more frequent and often accompanied by more severe neurologic deficits [5, 6] . TSC is characterized pathologically by the occurrence of multiple hamartomas in various organs, such as renal angiomyolipomas and cardiac rhabdomyomas [1, 7] . The neurologic manifestations are often quite disabling and include epilepsy, developmental delay, mental retardation and autism [1, 8] . The cerebrum is most frequently affected in TSC. Three types of nodular lesions are identified as cortical tubers, subcortical heterotopic nodules and subependymal giant cell astrocytomas (SEGAs). Histologically, these hamartomas contain abnormal giant cells that show evidence of abnormal differentiation of immature neuronal cells [9, 10] . Tumorigenesis in TSC is explained on the basis of loss of heterozygosity (LOH) involving either the
